ASCENTAGE PHARMA GROUP INTERNATIONAL
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$14.46
-2.85%
Alpha Vantage · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
-9.1%
3 months
-14.0%
6 months
-38.1%
1 year
-55.8%
Year to date
-44.9%
52-week range
$14.46 – $34.30
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$1.35B
P/E
-6.2
P/B
16.3
P/S
14.1
Revenue
$642.64M
Net income
-$1.47B
Diluted EPS
-15.8
Gross margin
93.90%
Net margin
-228.50%
Return on equity
-240.30%
Total debt
$2.09B
Cash
$1.9B
Free cash flow
—
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | — | — | — | — | — |
| Dec 31, 2025 | — | — | — | — | — |
| Dec 31, 2025 | — | — | — | — | — |
| Jun 30, 2025 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
| Dec 31, 2024 | — | — | — | — | — |
| Jun 30, 2024 | — | — | — | — | — |
| Dec 31, 2023 | — | — | — | — | — |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent AAPG news
All market newsNo ticker-linked stories are in the current archive.